XRAY icon

Dentsply Sirona

16.21 USD
-0.41
2.47%
At close Jul 11, 4:00 PM EDT
1 day
-2.47%
5 days
-1.46%
1 month
0.62%
3 months
26.94%
6 months
-13.13%
Year to date
-13.55%
1 year
-36.95%
5 years
-61.22%
10 years
-68.95%
 

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 14,000

0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

60% more call options, than puts

Call options by funds: $12.6M | Put options by funds: $7.89M

15% more repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 110

7% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 57

0% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 4 (+0) [Q1 2025]

1% less funds holding

Funds holding: 356 [Q4 2024] → 353 (-3) [Q1 2025]

1.45% less ownership

Funds ownership: 100.86% [Q4 2024] → 99.41% (-1.45%) [Q1 2025]

22% less capital invested

Capital invested by funds: $3.81B [Q4 2024] → $2.96B (-$851M) [Q1 2025]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$16
1%
downside
Avg. target
$21
27%
upside
High target
$25
54%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Barrington Research
Michael Petusky
30%upside
$21
Outperform
Maintained
12 May 2025
UBS
Kevin Caliendo
54%upside
$25
Buy
Maintained
9 May 2025
Piper Sandler
Jason Bednar
1%downside
$16
Neutral
Maintained
30 Apr 2025

Financial journalist opinion

Based on 12 articles about XRAY published over the past 30 days

Neutral
GlobeNewsWire
1 day ago
Dentsply Sirona to Host Second Quarter Conference Call on August 7th
CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.
Dentsply Sirona to Host Second Quarter Conference Call on August 7th
Positive
Zacks Investment Research
2 days ago
Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
1 week ago
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Neutral
Zacks Investment Research
1 week ago
XRAY or MMSI: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
XRAY or MMSI: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 week ago
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?
Positive
Benzinga
3 weeks ago
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Neutral
Accesswire
3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation
Positive
Zacks Investment Research
3 weeks ago
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
3 weeks ago
Should Value Investors Buy Dentsply Sirona (XRAY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Dentsply Sirona (XRAY) Stock?
Neutral
Accesswire
3 weeks ago
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Charts implemented using Lightweight Charts™